Literature DB >> 21415394

A novel role for calpain in the endothelial dysfunction induced by activation of angiotensin II type 1 receptor signaling.

Rosario Scalia1, Yulan Gong, Brett Berzins, Brin Freund, Danielle Feather, Gavin Landesberg, Gourav Mishra.   

Abstract

RATIONALE: The cytosolic protease calpain has been recently implicated in the vascular remodeling of angiotensin II (Ang II) type 1 receptor (AT(1)R) signaling. The role of Ang II/AT(1)R/calpain signaling on endothelial function, an important and early determinant of vascular pathology, remains though totally unknown. Accordingly, we investigated the role of calpain in the endothelial dysfunction of Ang II.
OBJECTIVE: To demonstrate a mechanistic role for calpain in the endothelial dysfunction induced by Ang II/AT(1)R signaling. To establish endothelial-expressed calpains as an important target of AT(1)R signaling. METHODS AND
RESULTS: Subchronic administration of nonpressor doses of Ang II to rats and mice significantly increased vascular calpain activity via AT(1)R signaling. Intravital microscopy studies revealed that activation of vascular expressed calpains causes endothelial dysfunction with increased leukocyte-endothelium interactions and albumin permeability in the microcirculation. Western blot and immunohistochemistry studies confirmed that Ang II/AT(1)R signaling preferentially activates the constitutively expressed μ-calpain isoform and demonstrated a calpain-dependent degradation of IκBα, along with upregulation of nuclear factor κB-regulated endothelial cell adhesion molecules. These physiological and biochemical parameters were nearly normalized following inhibition of AT(1)R or calpain in vivo. RNA silencing studies in microvascular endothelial cells, along with knockout and transgenic mouse studies, further confirmed the role of μ-calpain in the endothelial adhesiveness induced by Ang II.
CONCLUSIONS: This study uncovers a novel role for calpain in the endothelial dysfunction of Ang II/AT(1)R signaling and establishes the calpain system as a novel molecular target of the vascular protective action of renin-angiotensin system inhibition. Our results may have significant clinical implications in vascular disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21415394      PMCID: PMC6159903          DOI: 10.1161/CIRCRESAHA.110.229393

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  39 in total

1.  Identification of mu-, m-calpains and calpastatin and capture of mu-calpain activation in endothelial cells.

Authors:  K Fujitani; J Kambayashi; M Sakon; S I Ohmi; S Kawashima; M Yukawa; Y Yano; H Miyoshi; M Ikeda; N Shinoki; M Monden
Journal:  J Cell Biochem       Date:  1997-08-01       Impact factor: 4.429

2.  Angiotensin II type 1 receptor activation increases microvascular permeability via a calcium dependent process.

Authors:  Christopher R Newton; Brian Curran; Gregory P Victorino
Journal:  J Surg Res       Date:  2005-01       Impact factor: 2.192

3.  Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors.

Authors:  M Ruiz-Ortega; O Lorenzo ; M Rupérez; J Blanco; J Egido
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

4.  Effect of angiotensin II on microvascular permeability.

Authors:  Gregory P Victorino; Christopher R Newton; Brian Curran
Journal:  J Surg Res       Date:  2002-05-15       Impact factor: 2.192

5.  Venular basement membranes ubiquitously express matrix protein low-expression regions: characterization in multiple tissues and remodeling during inflammation.

Authors:  Mathieu-Benoît Voisin; Doris Pröbstl; Sussan Nourshargh
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

6.  Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver.

Authors:  Ramón Bataller; Erwin Gäbele; Robert Schoonhoven; Terry Morris; Mark Lehnert; Liu Yang; David A Brenner; Richard A Rippe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-05-28       Impact factor: 4.052

7.  Role of metabolism and receptor responsiveness in the attenuated responses to Angiotensin II in mice compared to rats.

Authors:  Lisa A Cassis; Jing Huang; Ming C Gong; Alan Daugherty
Journal:  Regul Pept       Date:  2004-02-15

8.  Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs.

Authors:  Doris M Tham; Baby Martin-McNulty; Yi-xin Wang; Dennis W Wilson; Ronald Vergona; Mark E Sullivan; William Dole; John C Rutledge
Journal:  Physiol Genomics       Date:  2002-10-02       Impact factor: 3.107

9.  Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation: the role of mu-calpain.

Authors:  Rosario Scalia; Yulan Gong; Brett Berzins; Li Juan Zhao; Kumar Sharma
Journal:  Diabetes       Date:  2007-04-19       Impact factor: 9.461

10.  Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.

Authors:  Emmanuel Letavernier; Joëlle Perez; Agnès Bellocq; Laurent Mesnard; Alexandre de Castro Keller; Jean-Philippe Haymann; Laurent Baud
Journal:  Circ Res       Date:  2008-02-07       Impact factor: 17.367

View more
  16 in total

Review 1.  Mechanisms of I/R-Induced Endothelium-Dependent Vasodilator Dysfunction.

Authors:  Ronald J Korthuis
Journal:  Adv Pharmacol       Date:  2017-12-08

2.  Calpain-10 Activity Underlies Angiotensin II-Induced Aldosterone Production in an Adrenal Glomerulosa Cell Model.

Authors:  Mutsa Seremwe; Rick G Schnellmann; Wendy B Bollag
Journal:  Endocrinology       Date:  2015-04-02       Impact factor: 4.736

3.  Critical role of calpain in inflammation.

Authors:  Jingjing Ji; Lei Su; Zhifeng Liu
Journal:  Biomed Rep       Date:  2016-10-19

4.  Calpain activation and neuronal death during early epileptogenesis.

Authors:  Philip M Lam; Marco I González
Journal:  Neurobiol Dis       Date:  2018-11-10       Impact factor: 5.996

Review 5.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

6.  Leukocyte Calpain Deficiency Reduces Angiotensin II-Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in Mice.

Authors:  Deborah A Howatt; Anju Balakrishnan; Jessica J Moorleghen; Latha Muniappan; Debra L Rateri; Haruhito A Uchida; Jiro Takano; Takaomi C Saido; Athar H Chishti; Laurent Baud; Venkateswaran Subramanian
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-10       Impact factor: 8.311

7.  Postprandial activation of leukocyte-endothelium interaction by fatty acids in the visceral adipose tissue microcirculation.

Authors:  Kyle J Preston; Inna Rom; Christine Vrakas; Gavin Landesberg; Zienab Etwebi; Sanae Muraoka; Michael Autieri; Satoru Eguchi; Rosario Scalia
Journal:  FASEB J       Date:  2019-08-08       Impact factor: 5.191

8.  Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation.

Authors:  Zhongjian Cheng; Xiaohua Jiang; Meghana Pansuria; Pu Fang; Jietang Mai; Karthik Mallilankaraman; Rajesh Kumar Gandhirajan; Satoru Eguchi; Rosario Scalia; Muniswamy Madesh; Xiaofeng Yang; Hong Wang
Journal:  Diabetes       Date:  2014-10-28       Impact factor: 9.461

Review 9.  G-Protein-Coupled Receptors in Heart Disease.

Authors:  Jialu Wang; Clarice Gareri; Howard A Rockman
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

10.  Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling.

Authors:  Yoko Kudo-Sakamoto; Hiroshi Akazawa; Kaoru Ito; Jiro Takano; Masamichi Yano; Chizuru Yabumoto; Atsuhiko T Naito; Toru Oka; Jong-Kook Lee; Yasushi Sakata; Jun-ichi Suzuki; Takaomi C Saido; Issei Komuro
Journal:  J Biol Chem       Date:  2014-06-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.